Nils-Erik Willman

Title: Nils-Erik Willman: Innovator in Pharmacological Compounds

Introduction

Nils-Erik Willman is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at therapeutic applications. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Willman's latest patents include innovative compounds that address various health issues. One of his notable inventions is a pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol, which includes compounds of formula (I) and their physiologically acceptable salts. These compounds are recognized for their potential use as therapeutic substances, pharmaceutical compositions, and methods for their preparation. Another significant patent involves urinary incontinence ameliorating dibenz/b,e/oxepin and dibenz/b,e/thiepin compounds, which have a general formula where X can be either O or S.

Career Highlights

Throughout his career, Nils-Erik Willman has worked with various companies, including Pharmacia AB. His expertise in pharmacological research has led to the development of innovative solutions in the medical field.

Collaborations

Willman has collaborated with notable individuals in his field, including Bengt C. Sjogren and Lennart G. Nordh. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Nils-Erik Willman is a distinguished inventor whose work in pharmacological compounds has paved the way for new therapeutic options. His contributions continue to influence the field of medicine and improve patient care.